Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Review

Choosing a first-line drug in the management of elevated blood pressure: What is the evidence? 1: Thiazide diuretics

James M. Wright
CMAJ July 11, 2000 163 (1) 57-60;
James M. Wright
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

Article Figures & Tables

Tables

  • Table 1: Dosing and cost of diuretics for the treatment of hypertension

    Table1
PreviousNext
Back to top

In this issue

CMAJ
Vol. 163, Issue 1
11 Jul 2000
  • Table of Contents
  • Index by author
  • Canadian Adverse Drug Reaction Newsletter (85-92)

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Choosing a first-line drug in the management of elevated blood pressure: What is the evidence? 1: Thiazide diuretics
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Choosing a first-line drug in the management of elevated blood pressure: What is the evidence? 1: Thiazide diuretics
James M. Wright
CMAJ Jul 2000, 163 (1) 57-60;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Choosing a first-line drug in the management of elevated blood pressure: What is the evidence? 1: Thiazide diuretics
James M. Wright
CMAJ Jul 2000, 163 (1) 57-60;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • What is a thiazide diuretic?
    • What is the evidence that thiazide diuretics reduce cardiovascular morbidity and mortality?
    • How efficacious are thiazide diuretics in reducing blood pressure?
    • How efficacious are thiazide diuretics in reducing left ventricular hypertrophy?
    • Do thiazide diuretics and other drugs differ in tolerability?
    • Do thiazide diuretics have advantages in terms of convenience or cost?
    • Conclusion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Statistics and drug utilization: Are prescribing rates really that high?
  • The value of industry-sponsored studies of initial antihypertensive therapies
  • Evidence based management of hypertension: What are the elements of good treatment for hypertension?
  • First-line drugs for hypertension
  • First-line drugs for hypertension
  • Choosing a first-line drug in the management of elevated blood pressure: What is the evidence? 3: Angiotensin-converting-enzyme inhibitors
  • Choosing a first-line drug in the management of elevated blood pressure: What is the evidence? 2: {beta}-Blockers
  • Google Scholar

More in this TOC Section

  • The efficacy and safety of sunscreen use for the prevention of skin cancer
  • Prone positioning for patients with hypoxic respiratory failure related to COVID-19
  • Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19
Show more Review

Similar Articles

Collections

  • Topics
    • Research methods & statistics
    • Drugs: cardiovascular system
    • Cardiology: hypertension

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire